Cancer Drug Offers a Cautionary Tale of Deregulating the FDA

To illustrate the dangers of Trump’s plans to deregulate the FDA, Susan Perry from MinnPost provides a cautionary tale about Tarceva, a drug approved by the FDA that proved to be ineffective for 90% of patients. 

Article →­